Jump to main content
eTG Complete
Index
Search
Home
Toxicology and Toxinology
Gamma-hydroxybutyrate (GHB) poisoning
Risk assessment for GHB poisoning
Toxicology and Toxinology
What is covered in these guidelines?
Poisons information centres
Poisoning in children
Risk assessment for poisonings: general approach
Treatment for poisoning: general approach
Observation and patient disposition for poisonings
Toxidromes
Alcohol poisoning
Amanita phalloides mushroom poisoning
Angiotensin converting enzyme inhibitor (ACEI) and angiotensin II receptor blocker (ARB) poisonings
Anticoagulant drug poisoning
Antidepressant drug poisoning
Antidiabetic drug poisoning
Antiepileptic drug poisoning
Antihistamine poisoning
Antipsychotic drug poisoning
Arsenic poisoning (acute)
Aspirin and other salicylate poisonings
Baclofen poisoning
Beta-blocker poisoning
Bupropion poisoning
Button battery ingestion
Calcium channel blocker poisoning
Carbon monoxide poisoning
Caustic ingestions
Chloroquine, hydroxychloroquine and quinine poisonings
Clonidine and guanfacine poisonings
Cocaine poisoning
Colchicine poisoning
Cyanide poisoning
Digoxin poisoning
Essential oil poisoning
Flecainide poisoning
Gamma-hydroxybutyrate (GHB) poisoning
Management overview for GHB poisoning
Risk assessment for GHB poisoning
Toxic dose
Clinical presentation
Key investigations
Treatment for GHB poisoning
Observation and patient disposition after GHB poisoning
References
Herbicide poisoning
Hydrocarbon poisoning
Hydrofluoric acid poisoning
Insecticide poisoning
Iron poisoning
Isoniazid poisoning
Lead poisoning
Lithium poisoning
Local anaesthetic poisoning
Marine envenoming and penetrating marine injuries
Marine poisoning
Methotrexate poisoning
Nicotine poisoning
Nitrous oxide poisoning
Nonsteroidal anti-inflammatory drug (NSAID) poisoning
Novel psychoactive substance poisoning
Opioid poisoning
Paracetamol poisoning
Poisoning from plants
Potassium poisoning (oral)
Snake bite
Spider bite
Stimulant drug poisoning
Superwarfarin poisoning
Theophylline and caffeine poisonings
Intravenous inotrope infusions (Appendix 11.1)
Risk assessment for GHB poisoning
Toxic dose
Clinical presentation
Key investigations
